Penserra Capital Management LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$136
-70.2%
81,542
-49.5%
0.00%
-66.7%
Q2 2023$457
-41.9%
161,542
+0.8%
0.01%
-43.8%
Q1 2023$787
-58.5%
160,290
-9.2%
0.02%
-61.9%
Q4 2022$1,895
-99.9%
176,486
+1.6%
0.04%
-8.7%
Q3 2022$1,625,000
-10.4%
173,686
-12.6%
0.05%
-6.1%
Q2 2022$1,814,000
-21.0%
198,686
+5.1%
0.05%
-10.9%
Q1 2022$2,297,000
-1.1%
189,074
-0.8%
0.06%
+10.0%
Q4 2021$2,322,000
-22.3%
190,676
-1.5%
0.05%
-19.4%
Q3 2021$2,988,000
-15.8%
193,496
-22.2%
0.06%
-3.1%
Q2 2021$3,550,000
-47.5%
248,859
-20.2%
0.06%
-48.8%
Q1 2021$6,766,000
+292.0%
311,713
+172.9%
0.12%
+204.9%
Q4 2020$1,726,000
+106.2%
114,205
+73.2%
0.04%
+28.1%
Q3 2020$837,000
-25.7%
65,920
-0.1%
0.03%
-44.8%
Q2 2020$1,127,000
+52.1%
65,957
+17.3%
0.06%
+16.0%
Q1 2020$741,000
+387.5%
56,214
+500.6%
0.05%
+400.0%
Q4 2019$152,000
-15.6%
9,360
-5.2%
0.01%
-33.3%
Q3 2019$180,0009,8760.02%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 2,799,058$42,350,00022.29%
Chescapmanager LLC 1,314,603$19,890,0002.42%
Prosight Management, LP 294,041$4,449,0002.06%
DAFNA Capital Management LLC 261,442$3,956,0001.18%
Cypress Capital Management LLC (WY) 81,269$1,230,0001.06%
KINGDON CAPITAL MANAGEMENT, L.L.C. 626,583$9,480,0001.02%
Carmignac Gestion 1,851,443$28,012,0000.29%
FARALLON CAPITAL MANAGEMENT LLC 2,465,000$37,295,0000.22%
Ikarian Capital, LLC 301,700$4,565,0000.20%
DISCIPLINED GROWTH INVESTORS INC /MN 689,899$10,438,0000.20%
View complete list of CARA THERAPEUTICS INC shareholders